4.5 Article

Clinical metabolomics paves the way towards future healthcare strategies

Journal

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
Volume 75, Issue 3, Pages 619-629

Publisher

WILEY
DOI: 10.1111/j.1365-2125.2012.04216.x

Keywords

biomarkers; clinical metabolomics; gut microflora

Ask authors/readers for more resources

Metabolomics is recognized as a powerful top-down system biological approach to understand genetic-environment-health paradigms paving new avenues to identify clinically relevant biomarkers. It is nowadays commonly used in clinical applications shedding new light on physiological regulatory processes of complex mammalian systems with regard to disease aetiology, diagnostic stratification and, potentially, mechanism of action of therapeutic solutions. A key feature of metabolomics lies in its ability to underpin the complex metabolic interactions of the host with its commensal microbial partners providing a new way to define individual and population phenotypes. This review aims at describing recent applications of metabolomics in clinical fields with insight into diseases, diagnostics/monitoring and improvement of homeostatic metabolic regulation.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available